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Abstract Background/purpose: Burning mouth syndrome (BMS) is a chronic condition pre-
senting as intraoral burning or dysesthesia, with a high preponderance in menopausal women.
This study aimed to examine the association between somatosensory dysfunction and BMS in
premenopausal, early postmenopausal, and late postmenopausal patients, using a standard-
ized Quantitative Sensory Testing (QST) protocol, and to determine the predictive value of
thermal or mechanical perception by QST for detecting BMS.
Materials and methods: An observational caseecontrol study was performed with 36 female
participants with BMS (12 premenopausal, 10 early postmenopausal, and 14 late postmeno-
pausal) and 42 age- and sex-matched healthy volunteers (21 premenopausal, 10 early postmen-
opausal, and 11 late postmenopausal). Neurophysiological tests were used to evaluate
somatosensory dysfunction at the tongue.
Results: Z-score in the late postmenopausal BMS group revealed a gain of function for the cold
pain threshold and heat pain threshold (Z Z 2.08 and 3.38, respectively). In the multiple
regression analysis with the Visual Analog Scale as the dependent variable, the vibration detec-
tion threshold predicted the severity of burning mouth sensation in the premenopausal group.
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+ MODEL
Please cite this article as: K. Ozasa, N. Noma, A. Young et al., Potential differences in somatosensory function during premenopause and
early and late postmenopause in patients with burning mouth syndrome: An observational caseecontrol study, Journal of Dental Sciences,
https://doi.org/10.1016/j.jds.2021.08.010
https://doi.org/10.1016/j.jds.2021.08.010
1991-7902/ª 2021 Association for Dental Sciences of the Republic of China. Publishing services by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.e- jds.com
Journal of Dental Sciences xxx (xxxx) xxx
Conclusion: Late postmenopausal patients with BMS showed an increased response of the ton-
gue to noxious thermal stimuli. This supports the theory that changes in sex hormones may
affect trigeminal somatosensory function, particularly during the late postmenopausal stage
in patients with BMS.
ª 2021 Association for Dental Sciences of the Republic of China. Publishing services by Elsevier
B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
Introduction
Burning mouth syndrome (BMS) is characterized by intraoral
numbness, stinging, and burning pain.1,2 Women are
affected 3 to 20 times more frequently than men, usually at
menopausal or postmenopausal ages. The World Health
Organization (WHO) defines menopause, also known as
climacteric, as the permanent cessation of menstruation
resulting from the loss of ovarian follicular activity.
Amenorrhea must occur for 12 consecutive months before
natural menopause is recognized.3,4 During menopause,
women experience various predictable symptoms and con-
ditions related to changes in sex hormone levels and aging.
Menopause typically occurs between 49 and 52 years of
age.5
Serum hormonal imbalance during menstruation,
pregnancy, and the perimenopausal period may result in
numerous systemic and local symptoms, including a
burning sensation in the oral mucosa.6,7 Woda et al.8
surmised that reduced synthesis of ovarian steroids
after menopause induces deficiency or dysfunction in
adrenal steroids, reducing the neuroprotective effects of
steroids on neural tissues. The predilection of BMS in
menopausal and postmenopausal women also suggests
reduced levels of sex hormones,6,7,9 which can influence
somatosensory function, may be a factor, and that
nociception in the mouth is particularly sensitive to
modulation by ovarian hormone levels.10 A study in
ovariectomized female rats showed an increased sensi-
tivity to nociceptive stimulation in the orofacial region.11
However, clinical behavioral studies have not verified
this in premenopausal or early and late postmenopausal
patients with BMS.
Patients with BMS often complain of pain when eating
hot or spicy foods.2,12 Quantitative sensory testing (QST)
studies of the pain threshold of patients with BMS have had
similar findings. Yilmaz et al. found that patients with BMS
were more sensitive to cold hyperalgesia than patients
with lingual nerve impairment.13 Grushka et al. reported
that heat pain tolerance was significantly decreased in
patients with BMS.14 QST alterations are not exclusive to
BMS. De Kruijf et al. reported a significant association
between years after menopause and cold and warmth
sensitivity thresholds in patients with chronic pain.15 In a
previous study, we found an association between so-
matosensory dysfunction and disease duration in patients
with BMS.12,16
We aimed to assess the somatosensory function in pre-
menopausal and early and late postmenopausal patients
with BMS, compared with healthy volunteers, and
investigate the association between QST data and stage of
menopause. In addition, we investigated the predictive
value of thermal and mechanical parameters for detecting
the severity of burning sensation.
Materials and methods
This study was approved by the Ethical Committee of
Nihon University School of Dentistry (EP16 D020-1) and was
conducted in accordance with the Helsinki Declaration.
Informed consent of all patients and volunteers was
mandatory. Fifty-four individuals gave their consent to
participate in this study. A total of 49 patients accepted
the invitation, and the other five declined to participate.
Out of the 49 patients, 13 were excluded, including five
patients who complained of intraoral burning sensation for
only 1 month (n Z 5), three due to a swab test that
showed candida albicans growth (n Z 3), two due to non-
burning dysesthetic sensation (n Z 2), and three due to
unknow menopause status (n Z 3). In the present study, a
total of 36 primary BMS patients were enrolled. The study
period was between April 2019 and March 2021.
The following definitions were used to determine post-
menopausal and BMS status in this study. Women who had
menstruated normally in each of the last three months, and
whose ages were between 30 and 50 years, were catego-
rized as premenopausal. Women whose last menstrual
period occurred >12 months prior were categorized as
postmenopausal. Postmenopausal women who reached
menopause 5 years prior were classified as the early
postmenopausal group, while those who had reached
menopause >5 years prior were classified as the late
postmenopausal group.17,18
This study included 36 women with BMS and 42 age-
matched healthy female volunteers. The BMS patients
were recruited from a tertiary outpatient pain clinic of
Nihon University Dental Hospital in Tokyo. All patients
were recruited by the same trained examiner (NN). Pa-
tients with BMS were divided into three groups: pre-
menopausal BMS (n Z 12; 40.1  6.0 years), early
postmenopausal BMS (n Z 10; 53.2  2.7 years), and late
postmenopausal BMS (n Z 14; 70.1  5.0 years). Like-
wise, the healthy volunteers were divided into three
groups: premenopausal control (n Z 21; 45.2  2.4
years), early postmenopausal control (n Z 10; 55.6  2.8
years), and late postmenopausal control (n Z 11;
64.9  10.8 years). The presence of intraoral sponta-
neous pain was assessed in patients with BMS using the
Visual Analog Scale (VAS: marked at one end with 0 and at
the other end with 100).




The QST protocol used in this study was based on that of the
German Research Network on Neuropathic Pain,19 and
consisted of the thermal and mechanical tests at the tip of
the tongue. The examiner was blind to the BMS and the
volunteer’s status of the participants and was not involved
in the recruitment. One healthy volunteer took non-
steroidal anti-inflammatory drugs (NSAIDs) for tension-
type headache 2e3 times per week. She was advised and
was comfortable stopping the medication use 48 h prior to
QST. Likewise, seven of the BMS patients took acetamino-
phen, antianxiety, and anticonvulsant medications regu-
larly. Following a consultation with their primary care
provider, they stopped the medications 48 h before the QST
session. They resumed the medication use immediately
after the sensory testing.
Thermal tests
Cold detection threshold (CDT), warmth detection
threshold (WDT), thermal sensory limen, cold pain
threshold, and heat pain threshold were determined with a
computer-controlled Peltier e type thermode (Somedic,
Sales AB, Hörby, Sweden; stimulation area 16 *16 cm2) and
the Classic Method of Limits.
Mechanical tests
The mechanical QST protocol used in this study consisted of
tests for the mechanical detection threshold (MDT), me-
chanical pain threshold (MPT), mechanical pain sensitivity
(MPS), dynamic mechanical allodynia (DMA), wind-up ratio
(WUR), vibration detection threshold, and pressure pain
threshold, as described previously.
Statistical analysis
Normal distribution was tested with the goodness of fit test.
For normally distributed data, we used the unpaired t-test
(parametric methods) for two sample analysis. When sam-
ples that did not meet the assumption of normal distribu-
tion we used non-parametric the ManneWhitney test. This
included the QST results of premenopausal, early post-
menopausal, and late postmenopausal patients with BMS
and healthy controls. All data are presented as
means  standard deviations (SD). To examine the differ-
ences between patients with BMS and healthy controls in
the QST variables, a Z-score transformation was performed
for all QST variables to provide a somatosensory profile.
The detailed method of Z-score calculation has been
described elsewhere.20 A positive Z-score indicated sensory
gain, and a negative Z-score indicated sensory loss. Z-
scores are presented as means  standard errors.
In addition, multiple regression analysis was performed
to define the contribution of the independent variables,
such as thermal parameters (CDT, WDT, thermal sensory
limen, cold pain threshold, and heat pain threshold) and
mechanical parameters (MDT, MPT, vibration detection
threshold, pressure pain threshold, WUR, and MPS) to the
dependent variable (VAS: spontaneous pain) in the pre-
menopausal, early postmenopausal, and late post-
menopausal patients with BMS. The DurbineWatson
statistic was used to test for the occurrence of serial cor-
relation in the residuals from the multiple regression
analysis when the data did not show a normal distribution.
All statistical analyses were performed using SPSS v.27 (IBM,
Tokyo, Japan). Significance level was set at p < 0.05 for all
statistical tests.
Sample size estimation
JMP Pro statistical software v. 15.0 (SAS Institute Inc, Cary,
NC, USA) was used to calculate the required number of
subjects per group to be able to detect differences be-
tween groups. Two sample means test was used to estimate
the per group sample size. The parameters required to run
the test (SD and the difference to detect) were selected
based on the previously published data.21 The SD of 2.0 and
difference to detect of 2.9 were used. The alpha level was
set to 0.05, and power was set to 0.8. Based on the selected
parameters, the required per group sample size was esti-
mated to be 9 to be able to detect significant differences
between the groups.
Results
Table 1 shows the raw data at the tongue for all QST in the
premenopausal, early postmenopausal, and late post-
menopausal BMS groups. Pressure pain threshold was
significantly decreased in the premenopausal BMS group
compared to premenopausal controls (p < 0.01:
ManneWhitney test). Among the early postmenopausal
groups, vibration detection threshold was significantly
decreased in the BMS group compared with controls
(p < 0.01: ManneWhitney test). In the late postmenopausal
groups, significant differences were observed in the com-
parison of cold pain threshold and heat pain threshold be-
tween controls and patients with BMS, indicating cold and
heat hyperalgesia at the tongue (p < 0.01 and p < 0.05,
respectively: ManneWhitney test) (Tables 1 and 2).
Z-score
In the premenopausal and early postmenopausal BMS
groups, the means of all the parameters on the tongue
remained within the 95% CI of the baseline reference
database (Z-scores within 1.96; Figs. 1e2). On the other
hand, in the late postmenopausal BMS group (Fig. 3a), a
mean gain of function by cold pain threshold and heat pain
threshold at the tongue (Z Z 2.08 and 3.38, respectively)
was observed (Fig. 3b).




A stepwise multiple regression analysis was performed with
spontaneous pain as the dependent variable. The model
using mechanical parameters (MDT, MPT, vibration detec-
tion threshold, pressure pain threshold, WUR, MPS)
explained 17.1% of variance in spontaneous pain in pre-
menopausal patients with BMS [adj. R2 Z 0.58; F Z 3.56;
p Z 0.025, DurbineWatson Z 2.087]. Vibration detection
threshold contributed significantly to the model, while the
other parameters did not (Table 3). There was no evidence
of the occurrence of DMA, which was not included in the
parameters as an independent variable.
The model with thermal parameters (CDT, WDT, thermal
sensory limen, cold pain threshold, and heat pain
threshold) was not significantly predictive for spontaneous
pain in premenopausal patients with BMS [adj. R2 Z 0.03;
F Z 0.93; p Z 0.30]. In the early postmenopausal BMS
group, the model was not predictive when the predictor
variables were mechanical [adj. R2 Z 0.32; F Z 0.63;
p Z 0.45] or thermal [adj. R2 Z 0.55; F Z 0.36; p Z 0.79].
Similarly, in the late postmenopausal BMS group, the model
was not predictive when the predictor variables were me-
chanical [adj. R2 Z 0.17; F Z 0.68; p Z 0.76] or thermal
[adj. R2 Z 0.38; F Z 2.64; p Z 0.06] (Table 4). Table 5
summarizes the clinical characteristics of the BMS pa-
tients and healthy controls, such as systemic diseases and
principal drugs.
Discussion
In the present study, the QST results for cold pain threshold
and heat pain threshold at the tongue were significantly
more sensitive in the BMS group than in the control group at
the late postmenopausal stage. In a previous QST study, De
Kruijf et al.15 found a significant association between years
after menopause and cold and warmth sensitivity thresh-
olds. One possible reason for the increased cold pain
threshold may be that drastic menopausal changes signifi-
cantly reduce neuroprotective steroids. This reduction in
neuroprotective and neuroregenerative capacities may
Table 1 Quantitative sensory testing results in pre-








CDT 2.63  1.29 1.84  0.86 3.91  3.04
WDT 3.52  2.25 2.52  0.94 3.75  3.16
TSL 2.28  2.91 1.37  1.12 2.10  1.46
CPT 12.41  7.38 13.38  6.54 16.10  0.51**
HPT 46.86  2.12 45.06  4.48 43.68  3.46*
MDT
(mN)
0.18  0.15 0.16  0.09 0.16  0.06
MPT
(mN)
37.84  44.09 60.36  54.0 37.88  20.07
MPS
(ratio)
9.05  10.38 13.32  14.35 14.06  16.47
WUR
(ratio)
3.46  2.97 2.65  1.51 2.72  1.25
VDT
(x/8)
5.89  0.84 4.92  0.64* 5.54  1.07
PPT
(kPa)
0.56  0.40** 0.90  0.56 0.55  0.26
BMS, burning mouth syndrome; CDT, cold detection threshold;
CPT, cold pain threshold;; HPT, heat pain threshold; MDT, me-
chanical detection threshold; MPT, mechanical pain threshold;
MPS, mechanical pain sensitivity; PPT, pressure pain threshold;
TSL, thermal sensory limen; VDT, vibration detection threshold;
WDT, warmth detection threshold; WUR, wind-up ratio.
For CDT and WDT, differences from baseline-temperature
(32 C) are shown.
There is no evidence of the occurrence of dynamic mechanical
allodynia.
Mean valuesSDs Premenopause control vs. premenopause BMS:
**p < 0.01, early postmenopause control vs. early postmeno-
pause BMS: *p < 0.05, late postmenopause control vs. late
postmenopause BMS: **p < 0.01.
Table 2 Quantitative sensory testing results in pre-








CDT 2.54  1.20 2.70  1.64 3.39  1.39
WDT 2.54  1.22 2.50  0.92 5.08  1.73
TSL 2.06  1.30 1.08  0.84 3.18  1.19
CPT 9.10  5.64 10.82  4.88 5.79  4.94
HPT 46.6  2.79 44.6  3.32 48.12  1.31
MDT
(mN)
0.16  0.09 0.16  0.09 0.36  0.26
MPT
(mN)
55.0  35.7 53.8  37.4 37.12  18.74
MPS
(ratio)
5.41  7.60 4.28  8.30 16.00  18.46
WUR
(ratio)
3.93  2.58 4.59  4.52 3.06  1.93
VDT
(x/8)
5.47  0.73 5.65  0.81 5.98  0.39
PPT
(kPa)
1.07  0.30 0.83  0.29 0.41  0.16
CDT, cold detection threshold; CPT, cold pain threshold; DMA,
HPT, heat pain threshold; MDT, mechanical detection threshold;
MPT, mechanical pain threshold; MPS, mechanical pain sensi-
tivity; PPT, pressure pain threshold; TSL, thermal sensory
limen; VDT, vibration detection threshold; WDT, warmth
detection threshold; WUR, wind-up ratio.
For CDT and WDT, differences from baseline-temperature
(32 C) are shown.
There is no evidence of the occurrence of dynamic mechanical
allodynia.
Mean valuesSDs Premenopause control vs. premenopause BMS:
**p < 0.01, early postmenopause control vs. early postmeno-
pause BMS: *p < 0.05, late postmenopause control vs. late
postmenopause BMS: **p < 0.01.
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preferentially put small Ad fibers at risk.22 Another possible
mechanism is that neuroactive steroids may directly or
indirectly affect cold sensitivity in postmenopausal patients
with BMS. Yilmaz et al.13 and Hartmann et al.23 also re-
ported cold hyperalgesia in patients with BMS but not in
patients with lingual nerve impairment.
The Z-score in the postmenopausal patients with BMS
also showed an increased response of the tongue to cold
pain stimulation (cold pain threshold Z-score Z 2.08). Ad
cold afferents seem to be impaired more often than C fibers
in patients with BMS, indicating an imbalance in the small
fiber input to the central nervous system.13 Zagury et al.24
reported an extended painful aftersensation following cold
application in atypical odontalgia patients compared with
control subjects. This suggests a neuropathic mechanism
involving central factors. The cold test may be a diagnostic
marker for central sensitization in patients with chronic
pain, such as BMS.
Figure 1 Z-score QST profiles of the tongue in patients with premenopausal BMS. a. Mean overall Z-scores. b. Overall scatter plot
profile. All QST variables are presented as Z-scores. A Z-score greater than 0 indicates increased sensation, and a Z-score less than
0 indicates loss of sensory function. Z-scores greater than 1.96 indicate values outside the 95% confidence interval of the baseline
values (gray zone indicates Z-scores less than  1.96). Abbreviations: cold detection threshold (CDT), warmth detection threshold
(WDT), thermal sensory limen (TSL), cold pain threshold (CPT), heat pain threshold (HPT), mechanical detection threshold (MDT),
mechanical pain threshold (MPT), vibration detection threshold (VDT), pressure pain threshold (PPT), wind-up ratio (WUR) and
mechanical pain sensitivity (MPS).
Figure 2 Z-score QST profiles of the tongue in patients with early postmenopausal BMS. a. Mean overall Z-scores. b. Overall
scatter plot profile. All QST variables are presented as Z-scores. A Z-score greater than 0 indicates increased sensation, and a Z-
score less than 0 indicates loss of sensory function. Z-scores greater than 1.96 indicate values outside the 95% confidence interval
of the baseline values (gray zone indicates Z-scores less than  1.96). Abbreviations: cold detection threshold (CDT), warmth
detection threshold (WDT), thermal sensory limen (TSL), cold pain threshold (CPT), heat pain threshold (HPT), mechanical
detection threshold (MDT), mechanical pain threshold (MPT), vibration detection threshold (VDT), pressure pain threshold (PPT),
wind-up ratio (WUR) and mechanical pain sensitivity (MPS).
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Late postmenopausal patients with BMS also showed an
increased response of the tongue to heat pain stimulation
(heat pain threshold Z-score Z 3.38). Grushka et al.14
demonstrated that patients with BMS were significantly
less tolerant of heat pain on the tongue than control sub-
jects. It is well known that the psychophysical responses to
noxious thermal stimuli are dependent not only on stimulus
intensity but also on the duration of the stimulus, inter-
stimulus interval, and characteristics of prior conditioning
stimuli. The duration of heat pain tolerance testing may
cause sensitization of the C fiber polymodal nociceptors
and Ad heat nociceptors in patients with BMS.25 This
sensitization may account for the decreased heat pain
tolerance of patients with BMS.
In this study, we investigated the association between QST
parameters and spontaneous pain at different stages of BMS
in an attempt to elucidate whether QST parameters can be
used as an early sign of BMS development. Multiple regression
analysis using mechanical parameters (MDT, MPT, VDT, PPT,
WUR, and MPS) as predictive variables for spontaneous pain
explained 17.1% of the variance in early stage of patients
with BMS, although vibration detection threshold alone was
found to be significant. Additionally, in the premenopausal
stage, pressure pain threshold at the tongue was significantly
lower in the BMS group than in the control group.
Martı́nez-Jauand et al.26 demonstrated that chronic pain
conditions with early age-of-onset menopause displayed
greater painful and non-painful mechanical sensitivity than
patients with late age-of-onset menopause. Consistent with
this, the prevalence of orofacial pain with migraine or
temporomandibular joint disorders seems to be much
higher during peak reproductive years.27,28 Hormonal
changes associated with pre-menopause or early meno-
pause may modulate pain hypersensitivity. Thus, ovarian
Figure 3 Z-score QST profiles of the tongue in patients with late postmenopausal BMS. a. Mean overall Z-scores. b. Overall
scatter plot profile. All QST variables are presented as Z-scores. A Z-score greater than 0 indicates increased sensation, and a Z-
score less than 0 indicates loss of sensory function. Z-scores greater than 1.96 indicate values outside the 95% confidence interval
of the baseline values (gray zone indicates Z-scores less than  1.96). Abbreviations: cold detection threshold (CDT), warmth
detection threshold (WDT), thermal sensory limen (TSL), cold pain threshold (CPT), heat pain threshold (HPT), mechanical
detection threshold (MDT), mechanical pain threshold (MPT), vibration detection threshold (VDT), pressure pain threshold (PPT),
wind-up ratio (WUR) and mechanical pain sensitivity (MPS).















Pressure pain threshold -0.45 1.87 0.12





















Cold pain threshold -0.31 0.69 0.51
Heat pain threshold -0.88 2.24 0.055
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hormones may exert their effect on somatosensory brain
activity by altering opiate neurotransmitters.29
To the best of our knowledge, this is the first study to
demonstrate that QST can generate objective information
(specifically the vibration detection threshold) that aids in
the early detection of BMS in premenopausal patients. BMS
is challenging to treat, though there is sufficient evidence
suggesting that for patients with significant anxiety, topical
clonazepam in combination with systemic anxiolytic drugs
may be an effective approach, particularly when intro-
duced early.30 Therefore, early detection and timely
referral to an orofacial pain specialist are crucial and may
reduce the chronic pain and associated cost.
A standardized battery of QSTs demonstrated that an
early transition to menopause may influence mechanical
pain sensitivity, while late menopause may influence ther-
mal pain sensitivity. Overall, our findings suggest that
changes in sex hormones may directly or indirectly affect
trigeminal somatosensory function during the post-
menopausal stage in patients with BMS.
This study had limitations. In the late postmenopausal
group, heat pain threshold and thermal sensory limen
trended toward significance in the multiple regression
analysis (p Z 0.055 and p Z 0.05 respectively; constant
p Z 0.06). It is possible that the small sample size
contributed to the insufficient power to detect significant
predictive values for those thermal tests.
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